Work

A multicenter prospective trial of sorafenib in patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC) refractory to prior sunitinib or bevacizumab

Year: 2008

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2008.26.15_suppl.5123

Authors: D. R. Shepard, B. I. Rini, J. A. Garcia, T. E. Hutson, P. Elson, T. Gilligan, C. Nemec, R. Lopez, D. Borner, R. Dreicer, R. M. Bukowski

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2241079867

Cites:

Cited by: 64

Related to: 10